Ftse Mib
33.090,93
-0,41%
DAX
18.997,66
-0,02%
S&P 500
5.917,11
0,00%
NASDAQ
18.966,14
-0,11%
Bitcoin
98.162,40
4,03%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aptevo Therapeutics Inc (APVO) Aptevo Therapeutics Inc (APVO) Notizie

Aptevo Therapeutics Inc

APVO
0,2615
-0,0285 (-9,83%)
Pre Mercato
Ultimo aggiornamento: 11:59:27
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202414:45EDGAR2Form 8-K - Current report
07/11/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:15EDGAR2Form 8-K - Current report
25/10/202422:30EDGAR2Form 8-K - Current report
03/10/202422:45EDGAR2Form DEF 14A - Other definitive proxy statements
23/9/202422:48EDGAR2Form PRE 14A - Other preliminary proxy statements
18/9/202422:07EDGAR2Form 8-K - Current report
17/9/202423:28EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/9/202414:09EDGAR2Form 8-K - Current report
30/8/202423:26EDGAR2Form S-1 - General form for registration of securities under..
09/8/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:15EDGAR2Form 8-K - Current report
07/8/202422:30EDGAR2Form 8-K - Current report
19/7/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202416:25APSBiotech Seeing Significant Buying Pressure Before The..
15/7/202414:19EDGAR2Form DEF 14A - Other definitive proxy statements
12/7/202422:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/6/202422:30EDGAR2Form S-1 - General form for registration of securities under..
10/6/202422:30EDGAR2Form 8-K - Current report
03/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:15EDGAR2Form 8-K - Current report
07/3/202414:56EDGAR2Form 8-K - Current report
05/3/202423:05EDGAR2Form 8-K - Current report
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202414:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202414:15EDGAR2Form 8-K - Current report
06/2/202422:37EDGAR2Form 8-K - Current report
31/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202414:00EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
16/1/202422:15EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
22/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
12/12/202322:19EDGAR2Form PRE 14A - Other preliminary proxy statements
22/11/202322:05EDGAR2Form S-3 - Registration statement under Securities Act of..
Apertura: Min: Max:
Chiusura: 0,29

La tua Cronologia

NASDAQ
APVO
Aptevo Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network